» Articles » PMID: 35204670

Biologically Relevant In Vitro 3D-Model to Study Bone Regeneration Potential of Human Adipose Stem Cells

Overview
Journal Biomolecules
Publisher MDPI
Date 2022 Feb 25
PMID 35204670
Authors
Affiliations
Soon will be listed here.
Abstract

Standard cell cultures may not predict the proliferation and differentiation potential of human mesenchymal stromal cells (MSCs) after seeding on a scaffold and implanting this construct in a bone defect. We aimed to develop a more biologically relevant in vitro 3D-model for preclinical studies on the bone regeneration potential of MSCs. Human adipose tissue-derived mesenchymal stromal cells (hASCs; five donors) were seeded on biphasic calcium phosphate (BCP) granules and cultured under hypoxia (1% O) for 14 days with pro-inflammatory TNFα, IL4, IL6, and IL17F (10 mg/mL each) added during the first three days, simulating the early stages of repair (bone construct model). Alternatively, hASCs were cultured on plastic, under 20% O and without cytokines for 14 days (standard cell culture). After two days, the bone construct model decreased total DNA (3.9-fold), (9.8-fold), and expression (19.6-fold) and metabolic activity (4.6-fold), but increased expression (38.6-fold) in hASCs compared to standard cultures. After seven days, the bone construct model decreased expression (64-fold) and metabolic activity (2.3-fold), but increased (54.5-fold) and expression (5.7-fold) in hASCs compared to standard cultures. The effect of the bone construct model on hASC proliferation and metabolic activity could be largely mimicked by culturing on BCP alone (20% O, no cytokines). The effect of the bone construct model on expression could be mimicked by culturing hASCs under hypoxia alone (plastic, no cytokines). In conclusion, we developed a new, biologically relevant in vitro 3D-model to study the bone regeneration potential of MSCs. Our model is likely more suitable for the screening of novel factors to enhance bone regeneration than standard cell cultures.

Citing Articles

Biomaterials combined with ADSCs for bone tissue engineering: current advances and applications.

Song Y, Wang N, Shi H, Zhang D, Wang Q, Guo S Regen Biomater. 2023; 10:rbad083.

PMID: 37808955 PMC: 10551240. DOI: 10.1093/rb/rbad083.


Effectiveness of biomechanically stable pergola-like additively manufactured scaffold for extraskeletal vertical bone augmentation.

Yang W, Wang C, Luo W, Apicella A, Ji P, Wang G Front Bioeng Biotechnol. 2023; 11:1112335.

PMID: 37057137 PMC: 10089125. DOI: 10.3389/fbioe.2023.1112335.

References
1.
Edelman J, Castro M, Wen Y . Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea. Invest Ophthalmol Vis Sci. 1999; 40(6):1112-23. View

2.
Rodriguez A, Meyerson H, Anderson J . Quantitative in vivo cytokine analysis at synthetic biomaterial implant sites. J Biomed Mater Res A. 2008; 89(1):152-9. PMC: 3864694. DOI: 10.1002/jbm.a.31939. View

3.
Mountziaris P, Mikos A . Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev. 2008; 14(2):179-86. PMC: 2962857. DOI: 10.1089/ten.teb.2008.0038. View

4.
Prins H, Schulten E, Ten Bruggenkate C, Klein-Nulend J, Helder M . Bone Regeneration Using the Freshly Isolated Autologous Stromal Vascular Fraction of Adipose Tissue in Combination With Calcium Phosphate Ceramics. Stem Cells Transl Med. 2016; 5(10):1362-1374. PMC: 5031181. DOI: 10.5966/sctm.2015-0369. View

5.
Loi F, Cordova L, Pajarinen J, Lin T, Yao Z, Goodman S . Inflammation, fracture and bone repair. Bone. 2016; 86:119-30. PMC: 4833637. DOI: 10.1016/j.bone.2016.02.020. View